Prognostic factors and failure pattern in lymph node-negative stage IB and II cervical carcinoma treated with radical hysterectomy and postoperative irradiation

Gynecologic and Obstetric Investigation

Volumn 52, Issue 1, 2001, Pages 13-17

  Aoki, Y ^a   Watanabe, M ^a   Sasaki, M ^a   Sato, T ^a   Kase, H ^a   Aida, H ^a   Kurata, H ^a   Tanaka, K ^a  

^a NIIGATA UNIVERSITY   (Japan)

Author keywords

Cervical cancer; Negative lymph nodes; Pelvic irradiation; Prognostic factor; Radical hysterectomy; Recurrence

Indexed keywords

ADULT; AGED; ARTICLE; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; FEMALE; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS; RADICAL HYSTERECTOMY; SURVIVAL TIME; UTERINE CERVIX CARCINOMA;

ADENOCARCINOMA; ADULT; AGED; CARCINOMA, SQUAMOUS CELL; COMBINED MODALITY THERAPY; FEMALE; HUMANS; HYSTERECTOMY; LYMPH NODES; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; SURVIVAL ANALYSIS; UTERINE CERVICAL NEOPLASMS;

EID: 0034831044     PISSN: 03787346     EISSN: None     Source Type: Journal    
DOI: 10.1159/000052933     Document Type: Article

References (22)

1. High-risk group in node-positive patients with stage IB, IIA, and IIB cervical carcinoma after radical hysterectomy and postoperative pelvic irradiation
2. Ovarian metastasis in stage IB and II cervical adenocarcinoma
3. Surgical pathologic factors that predict recurrence in stage IB and IIA cervical carcinoma patients with negative pelvic lymph nodes
4. Prospective surgical pathological study of disease free interval in patients with stage IB squamous cell carcinoma of the cervix: A Gynecologic Oncology Group study
5. Is there a role for adjuvant pelvic radiotherapy after radical hysterectomy in early stage cervical cancer
6. Stage IB and IIA cervical cancer with negative lymph nodes: The role of adjuvant radiotherapy after radical hysterectomy
7. Preoperative prognostic variables and the impact of postoperative adjuvant therapy on the outcomes of stage IB or II cervical carcinoma patients with or without pelvic lymph node metastases
8. A randomized trial of pelvic radiation therapy versus no further therapy in selected patients with stage IB carcinoma of the cervix after radical hysterectomy and pelvic lymphadenectomy: A Gynecologic Oncology Group Study
9. A prospective surgical pathological study of stage I squamous carcinoma of the cervix: A Gynecologic Oncology Group Study
10. A study of superficially invasive carcinoma of the cervix
11. The prognostic significance of tumor emboli in lymphatic or vascular space of the cervical stroma in stage IB squamous cell carcinoma of the cervix
12. Microinvasive carcinoma of cervix - The significance of lymphatic invasion and confluent patterns of stromal growth
13. Patients with squamous cell versus adeno(squamous) carcinoma of the cervix: What factors determine the prognosis?
14. Multivariate analysis of the histopathologic prognostic factors of cervical cancer patients undergoing radical hysterectomy
15. Identification of prognostic factors and risk groups in patients found to have nodal metastasis at the time of radical hysterectomy for early stage squamous carcinoma of the cervix
16. Surgically defined prognostic parameters in patients with early cervical carcinoma
17. Adjuvant chemotherapy after radical hysterectomy for cervical carcinoma: A comparison with effects of adjuvant radiotherapy
18. Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: A Gynecologic Oncology Group and Southwest Oncology Group study
19. Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer
20. Phase II trial of paclitaxel and cisplatin in metastatic and recurrent carcinoma of the uterine cervix
21. Paclitaxel and cisplatin as first-line therapy in recurrent or advanced squamous cell carcinoma of the cervix: A Gynecologic Oncology Group Study
22. A randomized trial of adjuvant chemotherapy after radical hysterectomy in stage Ib-IIa cervical cancer patients with pelvic node metastases